CMC and Spine Wave announces manufacturing agreement for NuCore
18-Aug-2006
By:Diana Morgan
CMC Biopharmaceuticals A/S, a Copenhagen based contract manufacturing organization, and Spine Wave , Inc. a developer of advanced materials, techniques, and implant systems for spine surgery based in Shelton, CT announced today that they have entered into a manufacturing agreement for the cGMP production of the recombinant protein component of Spine Wave’s NuCore™ Injectable Nucleus. The product will be manufactured at CMC’s facility in Copenhagen, Denmark, for commercial in-market supply.
Read the entire pdf press release
